ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 159

$331K Total Retail Price of All Prescriptions

Rank: 19 out of 159

241 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 241 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 241 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 4,984 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $110 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 310 240 1 2
LISINOPRIL 288 230 2 5
OMEPRAZOLE 253 161 3 6
METFORMIN HCL 250 187 4 12
FUROSEMIDE 221 193 5 13
WARFARIN SODIUM 199 198 6 11
HYDROCODONE-ACETAMINOPHEN 198 107 S3 7 1
OXYCODONE-ACETAMINOPHEN 170 82 S2 8 25
OXYCODONE HCL 166 27 S2 9 45
ALENDRONATE SODIUM 135 104 10 22
ZOLPIDEM TARTRATE 124 74 11 20
METOPROLOL TARTRATE 123 83 12 21
POTASSIUM CHLORIDE 122 122 13 26
PRAVASTATIN SODIUM 119 83 14 68
HYDROCHLOROTHIAZIDE 118 113 15 32
SIMVASTATIN 112 91 16 4
NABUMETONE 112 69 16 114
TAMSULOSIN HCL 109 77 18 3
DILTIAZEM 24HR CD 106 55 19 130
TRIAMTERENE-HCTZ 88 62 20 151
GABAPENTIN 86 35 21 8
SERTRALINE HCL 84 56 22 41
FLUTICASONE PROPIONATE 78 38 23 15
LANTUS 76 40 24 35
LEVOXYL 74 66 25 117
GLIPIZIDE ER 74 36 25 130
GLIMEPIRIDE 70 39 27 111
ALLOPURINOL 69 47 28 51
LOVASTATIN 67 41 29 94
FLUOXETINE HCL 64 40 30 85
FENTANYL 62 22 S2 31 56
AMITRIPTYLINE HCL 59 25 R 32 73
ATORVASTATIN CALCIUM 58 46 33 19
MORPHINE SULFATE ER 54 29 S2 34 65
TRAZODONE HCL 54 35 34 61
ACTONEL 52 52 36 181
METOPROLOL SUCCINATE 52 40 36 36
PREDNISONE 52 46 36 7
SYNTHROID 52 44 36 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.